|Articles|June 1, 1999

Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
Volume 5
Issue 8 Suppl

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Author(s)Arthur Kavanaugh, MD

Download PDF: Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction

over 27 years ago

Article

Methotrexate Therapy in the Year 2000: Outstanding Questions

over 27 years ago

Article

State-of-the-Art Combination Therapy in 1999

over 27 years ago

Article

Assessing New Therapies for RA: Defining New Expectations for Treatment; New Therapies in Clinical Practice: Issues of Cost and Access

over 27 years ago

Article

The Emerging Role of Anti-TNF Therapy in the Treatment of Rheumatoid Arthritis

over 27 years ago

Article

Selected Abstracts

over 27 years ago

Article

CME Quiz

over 27 years ago

Article

Bibliography

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

CKM syndrome | Image credit: catalin - stock.adobe.com

Simple Workflow Fixes Can Close CKM Care Gaps, Clinicians Say

ByLaura Joszt, MA

September 16th 2026

Atopic dermatitis | Image credit: Ольга Тернавская - stock.adobe.com

Clinicians Chart the Barriers That Keep Atopic Dermatitis Undertreated

BySkylar Jeremias

September 16th 2026

Woman getting her eyes checked | Image credit: N F/peopleimages.com - stock.adobe.com

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

ByStella Ko, PharmD, MS,David Tabano, PhD,Mona Kilany, PhD,Kimberly Jinnett, PhD, MSPH,Victor Kirksey, PhD,Reg Ledesma, MS,Sarah Mossburg, PhD,Charlene Nguyen, MPP, BSc,Bryan A. Wilson, PhD, MBA

September 15th 2026

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Articles in this issue

Related Content

Simple Workflow Fixes Can Close CKM Care Gaps, Clinicians Say

Clinicians Chart the Barriers That Keep Atopic Dermatitis Undertreated

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

5 Things to Know About the 2026 ESC Heart Failure Guidelines

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD

Tozorakimab Benefits Current and Former Smokers: Frank Sciurba, MD

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials